作为白血病的诊断,预后和治疗标志物的C型莱克类分子-1
Hamed Soleimani Samarkhazan1, Sara Zehtabcheh2, Sajjad Peyvasteh3
1Student Research Committee, Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Molecular biology reports
|May 16, 2025
概括
类型C的甲酸样分子-1 (CLL-1) 是白血病治疗的有前途的标. 它在急性髓性白血病 (AML) 细胞上的高表达为新型免疫疗法和监测最小残留疾病 (MRD) 提供了潜力.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 白血病仍然是一个重大的瘤挑战,需要新的生物标志物来改善患者的治疗结果.
- 目前的诊断和治疗策略需要改进,以解决白血病发病的复杂性.
研究的目的:
- 审查白血病中C型甲酸样分子-1 (CLL-1) 的结构,功能和表达模式.
- 探索CLL-1作为治疗点,诊断标记物和最小残留疾病 (MRD) 监测的潜力.
- 突出CLL-1在开发针对白血病的新型免疫治疗策略中的作用.
主要方法:
- 关于CLL-1及其与白血病的关系的现有文献的叙事综述.
- 对白血病细胞上的CLL-1表达模式的分析,特别是急性髓性白血病 (AML) 爆发.
- 评估CLL-1在诊断,MRD监测和免疫疗法开发方面的潜力.
主要成果:
- CLL-1在急性髓性白血病 (AML) 爆发上高度表达,表明其作为特定点的潜力.
- 一致的CLL-1表达支持其用于最小残留疾病 (MRD) 监测的实用性.
- 在白血病治疗中,CLL-1为创新的免疫治疗方法提供了机会.
结论:
- CLL-1是一种有前途的治疗标和白血病的生物标志物,特别是AML.
- 进一步了解CLL-1的作用可以导致更有针对性和有效的白血病治疗.
- 对CLL-1的研究为白血病管理中的诊断工具和免疫疗法开辟了新的途径.
更多相关视频
08:00A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
22.3K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
01:25Selectins
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...